Skip to main content

What the FDA labels say about taking them together

Atorvastatin and levoketoconazole

Levoketoconazole's FDA label of March 10, 2026 names atorvastatin in its drug interactions section; the atorvastatin labels PlainMeds reads (2) do not name levoketoconazole. The levoketoconazole label: “Concomitant use of RECORLEV with these substrates is contraindicated or not recommended Atorvastatin:”

Check it at the source: the atorvastatin FDA label on DailyMed (effective April 15, 2024, Viatris Specialty LLC); the levoketoconazole FDA label on DailyMed (effective March 10, 2026, Xeris Pharmaceuticals, Inc.).

What does the atorvastatin label say about levoketoconazole?

Atorvastatin's label (effective April 15, 2024) and its 1 other brand-application label do not name levoketoconazole in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lipitor), NDA020702 (Upjohn), as published by Viatris Specialty LLC, effective April 15, 2024 (SPL set a60cc18b-0631-4cf0-b021-9f52224ece65), via openFDA; the full label on DailyMed

What does the levoketoconazole label say about atorvastatin?

Levoketoconazole label, drug interactions

Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1 ) Atorvastatin:

Source: FDA drug label (Recorlev), NDA214133 (Strongbridge), as published by Xeris Pharmaceuticals, Inc., effective March 10, 2026 (SPL set d4c5fead-bc4a-fb02-e053-2a95a90ae4fc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

59Atorvastatin generic labelers
0Levoketoconazole generic labelers
AtorvastatinLevoketoconazole
Labeled forHigh cholesterol, Angina, High triglycerides, Heart attack and coronary artery diseasen/a
Boxed warningNoYes
Pharmacy cost (NADAC)$0.0228 per tablet 10 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?